IFNA1 and COVID-19: Indeed, published peripheral immune studies comparing mild and severe COVID-19 also observe diminished type I and type III IFN abundances in severe cases and note restricted IFN-stimulated gene expression among circulating immune cells (Galani et al., 2021; Hadjadj et al., 2020; Stephenson et al., 2021).